Jardiance Approved for Adults With Chronic Kidney Disease
WEBSeptember 25, 2023. The Food and Drug Administration (FDA) has approved Jardiance ® (empagliflozin) to reduce the risk of sustained decline in estimated glomerular filtration rate (eGFR), end ...
Study: Ibuprofen Found Safest NSAID for the Kidney
WEBMay 10, 2021 · Ibuprofen was the safest NSAID, conferring a significant 12% increased risk of incident eGFR less than 60, 32% increased risk of an eGFR decline of 30% or greater, and 34% increased risk of the ...
The Potential Dangers of Ketogenic Diets in Kidney Disease
WEBAugust 19, 2021. Higher-protein ketogenic (keto) diets may hasten kidney failure and cause other medical problems in patients with kidney disease, according to the most comprehensive review yet of ...
Time to Say Goodbye to the DRE for Prostate Cancer Screening
WEBJanuary 12, 2021. Screening and assessing for prostate cancer (PCa) is a major component of a urologist’s practice. For most urologists, part of this process includes the digital rectal ...
Cranberry Juice Good for Preventing Urinary Tract Infection
WEBJul 25, 2024 · References: Moro C, Phelps C, Veer V, et al. Cranberry juice, cranberry tablets, or liquid therapies for urinary tract infection: a systematic review and network meta-analysis. Eur Urol Focus ...
PSA Levels After Prostate Cancer Radiation Therapy Prognostic
WEBMay 28, 2024 · The 10-year PCSM rates for the RT alone, RT plus short-term ADT, and RT plus long-term ADT groups were 11.7%, 12.8%, and 12.1%, respectively, for the men with a PSA value of 0.1 ng/mL or higher ...
Farxiga Approved for Patients With CKD at Risk of Progression
WEBMay 4, 2021. The Food and Drug Administration (FDA) has approved Farxiga ® (dapagliflozin) to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end stage kidney ...
Nerve Invasion in Intermediate-Risk Prostate Cancer Ups Risk for …
WEBAug 22, 2024 · Autonomic nerve invasion in patients with intermediate-risk prostate cancer with extraprostatic spread may increase the risk for biochemical recurrence (BCR) or early adjuvant therapy after ...
Atrasentan Reduces Proteinuria in IgA Nephropathy
WEBMay 30, 2024. Atrasentan, an investigational potent and selective oral ETA receptor antagonist, reduced proteinuria at 36 weeks in patients with IgA nephropathy at high risk for progression ...
Some Men With PI-RADS 5 Lesions Can Forgo Systematic Prostate …
WEBJuly 28, 2021. Urologists may be able to skip systematic biopsy (SB) and perform targeted prostate biopsy (TB) alone in men with PI-RADS 5 lesions and a PSA density greater than 15%, a new study ...